跳至主要内容
临床试验/NCT07723287
NCT07723287暂停不适用

Risk Factors for Drug-Resistant Epilepsy in Children: A Prospective Cohort Study

Pham Ngoc Thach University of Medicine1 个研究点 分布在 1 个国家目标入组 375 人开始时间: 2026年1月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
暂停
入组人数
375
试验地点
1
主要终点
Development of Drug-Resistant Epilepsy

研究概览

简要总结

This prospective cohort study evaluates clinical, electroencephalographic predictors of drug-resistant epilepsy in children. Predictive statistical and machine-learning models will be developed to facilitate early identification of children at high risk for drug-resistant epilepsy.

详细描述

Epilepsy is one of the most common neurological disorders in childhood. Approximately one-third of pediatric patients eventually develop drug-resistant epilepsy despite appropriate antiseizure medication treatment. Early identification of children at high risk of drug resistance may facilitate timely referral for advanced therapies including epilepsy surgery, ketogenic diet, or neuromodulation.

This prospective cohort study aims to identify independent predictors of drug-resistant epilepsy in children treated at Children's Hospital 1, Ho Chi Minh City, Vietnam. Clinical characteristics, electroencephalography findings, neuroimaging, genetic testing, metabolic investigations, treatment response, and developmental outcomes will be prospectively collected.

Cox proportional hazards regression will be used to identify independent predictors of drug resistance. Machine learning models including logistic regression and random forest will subsequently be developed and internally validated to predict drug-resistant epilepsy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children younger than 16 years, including neonates.
  • Diagnosed with epilepsy according to International League Against Epilepsy criteria.
  • Receiving treatment or follow-up at Children's Hospital
  • Parent or legal guardian provides informed consent.
  • Expected follow-up of at least 12 months.

排除标准

  • Poor treatment adherence.
  • Insufficient baseline data.
  • Lost to follow-up.
  • Psychogenic nonepileptic seizures.
  • Severe systemic illness interfering with antiseizure medication.
  • Acute symptomatic seizures.

研究组 & 干预措施

Children with newly diagnosed epilepsy

Children with newly diagnosed epilepsy enrolled in a prospective observational cohort and followed longitudinally to determine the development of drug-resistant epilepsy and identify predictors of drug resistance.

干预措施: No Intervention: Observational Cohort (Other)

结局指标

主要结局

Development of Drug-Resistant Epilepsy

时间窗: Minimum 12 months after initiation of antiseizure medication

Development of drug-resistant epilepsy according to the International League Against Epilepsy definition after failure of two appropriately selected and tolerated antiseizure medications.

次要结局

  • Time to drug-resistant epilepsy(Up to 36 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hong Tang

Principal Investigator

Pham Ngoc Thach University of Medicine

研究点 (1)

Loading locations...

相似试验

Risk Factors for Drug-Resistant Epilepsy in Children | 临床试验